4S. Koulouri,R. J. Acherman,P. C. Wong,L. S. Chan,A. B. Lewis. Utility of B-Type Natriuretic Peptide in Differentiating Congestive Heart Failure from Lung Disease in Pediatric Patients with Respiratory Distress[J] 2004,Pediatric Cardiology(4):341～346
4Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain[J]. Nature, 1988, 332(6159) :78-81.
5Morrow DA, de Lemos JA, Blazing MA, Sabatine MS, Murphy SA, Jarolim P, et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease [ J ]. JAMA, 2005, 294 (22) :2866-2871.
6Price JF, Thomas AK, Grenier M, Eidem BW, O'Brian Smith E, Denfield SW, et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction [ J ]. Circulationtion, 2006, 114 (10) : 1063-1069.
7Maher KO, Reed H, Cuadrado A, Simsic J, Mahle WT, Deguzman M, et al. B-type natriuretic peptide in the emergency diagno- sis of critical heart disease in children[J]. Pediatrics, 2008, 121 (6) :e1484-e1488.
8Aggarwal S, Pettersen MD, Bhambhani K, Gurczynski J, Thomas R, L'Ecuyer T. B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children [ J ]. Pediatr Blood Cancer, 2007, 49(6) :812-816.
9Nasser N, Perles Z, Rein A J, Nir A. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis[ J]. Pediatr Cardiol, 2006, 27(1) :87-90.
10Reithmann C, Reber D, Kozlik-Feldmann R, Netz H, Pilz G, Welz A, et al. Post-recepter defect of adenylyl cyclase in severely failing myocardium from children with congenital heart disease [ J]. Eur J Pharmacol, 1997, 330( 1 ) :79-86.
